MedTrace Logo

Effectiveness of TechCR Among CHD Patients

NCT04862351 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2024-04-17

No results posted yet for this study

Summary

During this ongoing pandemic, there is a crucial need for innovative approaches to deliver CR programmes other than frequent face-to-face sessions at the centre-based CR to reduce the number of times people come close in contact with others or gathering in large groups. This is a single setting, 2-arm parallel randomised clinical trial which aims to examine the effects of technology-assisted interventions in hybrid cardiac rehabilitation (TecHCR) among the coronary heart disease patients. Eligible participants will be randomly assigned into either intervention group (IG) or control group (CG) in 1:1 ratio using the computerised permuted blocks, alternating block sizes of 4 or 6. All participants will be followed up for three months and six months with data collection at baseline, (T0), three-month (T1) and six-month (T2) time points.

Conditions

Interventions

BEHAVIORAL

exercise training for TechCR

3 times of supervised exercise training at the centre-based, outpatient cardiac rehabilitation clinic

BEHAVIORAL

audio/video conference

weekly audio/video conference

BEHAVIORAL

educational video

weekly for 6 weeks, duration of video about 10-15 minutes

BEHAVIORAL

Daily log

daily dietary and exercise log

BEHAVIORAL

exercise training for centre-based

6 times of supervised exercise training

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Mei Sin Chong · Chinese University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-26
Primary Completion
2023-10-31
Completion
2023-10-31

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04862351 on ClinicalTrials.gov